Search results
Author(s):
Liesa Castro
,
Svante Zipfel
,
Samer Hakmi
,
et al
Added:
4 years ago
Author(s):
John G Coghlan
,
Alexander MK Rothman
,
Stephen P Hoole
Added:
3 years ago
Line Melgaard
Author
Gary E Raskob
Job title: PhD
Author
Mert Dumantepe
Job title: Associate Professor of Cardiovascular Surgery
Author
Kush R Desai
Research Area(s) / Expertise:
Job title: Associate Professor of Radiology, Surgery and Medicine; Director, Deep Venous Interventions
Author
Author(s):
Line Melgaard
Added:
5 years ago
Dr Line Melgaard (Aalborg University, Aalborg, DK) discusses the thromboembolic risk in patients with atrial fibrillation and
valvular heart disease according to the EHRA Type 2 definition.
Filmed on site at EHRA 2019 by Radcliffe Cardiology
Questions:
1. What was the need to evaluate atrial fibrillation patients specifically with valvular heart disease?
2. How was the study set up to…
View more
Author(s):
Ole De Backer
Added:
4 years ago
Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) provides an update from theGALILEO-4D trial, discussing the comparison ofa Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves.
What is the GALILEO-4D study and how is it related to the main GALILEO trial?
What is the design of the study and what…
View more
Author(s):
Hermann Reichenspurner
Added:
3 years ago
Author(s):
Stuart J Head
,
Ad JJC Bogers
,
A Pieter Kappetein
Added:
3 years ago
Valvular Heart Surgery
The field of cardiac surgery is urgently in need of new anticoagulant agents. Approximately 300,000 prosthetic valves are implanted yearly, after which lifelong anticoagulation therapy is mandatory as thromboprophylaxis. To date, vitamin K antagonists (VKAs), such as warfarin, remain the only licensed agents to prevent mechanical valve-induced thromboembolic events but…
View more